PLEASE JOIN US AT
AONN+ Midyear Conference 2022
May 11th – 15th I Austin, Texas
Agendia is excited to attend the Academy of Oncology Nurse & Patient Navigators (AONN) Midyear Conference
We will be showcasing the most recent data at this hybrid event, which builds upon existing clinical research that demonstrates the efficacy of MammaPrint and BluePrint testing to support treatment planning decisions, highlights Agendia’s ongoing trials that have the potential to impact patient treatment and outcomes.
Product Theater
Title: Genomic Profiling in Early Stage Breast Cancer
Speaker: William Audeh, MD, MS
Date & Time: May 14, 2022 – 9:45 AM- 10:45 AM CDT
Location: Brazos Ballroom, Omni Barton Creek, Austin, TX
Description: The presentation will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint and BluePrint, in patients with breast cancer. Dr. William Audeh, Chief Medical Officer at Agendia will discuss how real-world evidence and published data can be used to improve outcomes and patient management based on MammaPrint and BluePrint results. Attendees will participate in an interactive Q&A at the end of the presentation.
About the speaker
William Audeh, Agendia’s Chief Medical Officer, is a medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.
